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Abstract
Objective: Habituation of visual-evoked potentials (VEPs) is typically described as deficient interictally in migraine
patients, supposedly indicating altered cortical excitability. Use of this parameter for monitoring changes over time,
e.g. under treatment, requires demonstration of test-retest reliability.
Methods: VEPs were recorded interictally in 41 episodic migraine patients and 40 controls. N75–P100 amplitudes were
measured over six consecutive blocks of 75 VEPs each. Amplitude regression slopes and block ratios were used to
quantify VEP habituation. Test-retest reliability was assessed over 15 minutes and two to three weeks.
Results: Controls showed significantly more negative VEP habituation slopes than migraine patients (0.21 0.40 vs.
0.04 0.46mV/block, p< 0.05). Results were similar for block ratios, though, in the migraine group, VEP habituation
significantly increased from test to two- to three-week retest (p< 0.05). In addition, VEP habituation test-retest cor-
relations were mostly poor both in migraine patients and controls (intraclass correlation coefficients, 15 minutes: 0.13
to 0.30, two to three weeks: 0.07 to 0.59).
Conclusions: Deficient VEP habituation in migraine was confirmed. However, the test-retest reliability of VEP habitu-
ation was rather weak. Therefore, we suggest that VEP habituation should be used for evaluation of cortical excitability
under treatment only at the group level and only when a control group with sham treatment is included.
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Introduction
Migraine is associated with considerable individual
suffering and socioeconomic impact (1). It is ranked
by the World Health Organization as cause number 19
of worldwide disability among all diseases (2). The
underlying mechanisms are only incompletely under-
stood. An interictal lack of habituation to sensory
stimulation (e.g. visual, auditory, somatosensory and
nociceptive) has been repeatedly reported (3). Also
responses related to mental functions, such as contin-
gent negative variation and P300 amplitude in oddball
paradigms, show an interictal lack of habituation
(4,5). Therefore, the lack of habituation is seen as a
major neurophysiological hallmark of migraine and
has been interpreted as being the consequence of
increased cortical excitability, decreased cortical
inhibition or reduced cortical pre-activation. This
change in cortical excitability is regarded as having a
causal role in migraine pathogenesis (6). Habituation
of visual-evoked potentials (VEPs) is easy to assess,
cost effective, and may be of special relevance to
migraine because visual symptoms are common in
migraine (photophobia, visual aura) (7). For assess-
ment of VEP habituation, pattern-reversal VEPs are
usually averaged in blocks of 50–100 and amplitude
slopes or first-to-last block amplitude ratios are calcu-
lated over five to six blocks (8–10). Most studies find
that healthy individuals exhibit a significant habitu-
ation of VEP amplitudes while migraine patients in
the interictal period do not (8,11,12). There are several
pharmacological and psychological interventions
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hypothesized to reduce migraine frequency and/or sever-
ity by regulating cortical excitability, e.g. antiepileptic
drugs or psychological techniques such as progressive
muscle relaxation or biofeedback (13–16). It would
therefore be an obvious approach to use VEP habitu-
ation for monitoring of treatment success, for evaluation
of new treatment approaches, and maybe even for indi-
vidual prediction of treatment success. However, before
using VEP habituation for longitudinal evaluation of
treatment effects at the group level or individual
level, test-retest reliability has to be demonstrated.
In the present study, we confirmed group differences in
VEP habituation between interictal migraine patients
(n¼ 41) and healthy controls (n¼ 40) and evaluated
the test-retest reliability of VEP habituation over a
short period of 15 minutes (15 migraine patients, 15 con-
trols) and over a longer period of two to three weeks (15
migraine patients, 24 controls). Test-retest reliability at
the group level was assessed by comparing group means
at test and retest. Test-retest reliability at the individual




The study was conducted in accordance with the
Declaration of Helsinki and approved by the local ethics
committee at the University of Munich. Prior to partici-
pation, informed written consent was obtained. Patients
with episodic migraine and healthy controls with normal
or corrected-to-normal vision were recruited by advertise-
ments on the hospital and university campus. Presence of
episodic migraine with or without aura and absence of
other headache types was diagnosed according to the cur-
rent International Classification of Headache Disorders
(ICHD-III beta version) (17) by an experienced physician
of the outpatient headache clinic at the Department of
Neurology. Healthy controls had to be free of any head-
aches. Participants had to be free of migraine-preventive
medication for at least four weeks prior to participation.
Analgesic medication and triptans were allowed, but not
within 48 hours before the experiment. Migraine patients
were tested interictally, meaning they were free of head-
ache for at least 48 hours before and after the experimental
session, which was assessed by a telephone or email inter-
view 48 hours after the recording. In addition, all partici-
pants had to meet the following criteria: (1) age above 18
years, (2) sufficient knowledge of the German language,
(3) no major neurological, psychiatric or medical condi-
tions (apart from migraine in the patient group), (4) no
chronic pain disorders, and (5) not pregnant or breast-
feeding. All migraine patients completed the Migraine
Disability Assessment Scale (MIDAS) (18,19). In addition,
migraine patients were interviewed regarding headache
frequency (days per month in the last month), headache
intensity (average during the last month) and first onset of
migraine. The period of recruitment was from July 2013
until April 2014. Follow-up was conducted from April
2015 to July 2015.
Group differences and test-retest reliability were
assessed. Analysis of group differences in VEP habitu-
ation was based on all migraine patients for whom at
least one interictal measurement could be obtained
(n¼ 41) and on all controls (n¼ 40). For test-retest ana-
lysis over 15 minutes, data from 15 interictal migraine
patients and 15 controls was available and for test-
retest analysis over two to three weeks, data from 15
interictal migraine patients and 24 controls were avail-
able. A larger number of migraine patients had been
tested for the group comparison (n¼ 50), for the test-
retest over 15 minutes (n¼ 21) and for the test-retest
over two to three weeks (n¼ 31), but some of the
migraine patients had to be excluded from analysis
because they developed headache within 48 hours
after the experiment. The high incidence of headache
in the two- to three-week retest condition is likely due
to the use of transcranial magnetic stimulation to deter-
mine magnetic suppression of visual accuracy ((20)
within the same experimental sessions, but after meas-
urement of VEPs (data reported elsewhere (21)).
Occipital transcranial stimulation may have induced
headaches in some of the patients (22).
VEP recording
VEP recording was performed according to inter-
national standards (23,24). Participants were seated in
a relaxed position in a quiet room with dimmed light.
The screen was placed 135 cm in front of their eyes and
the right eye was covered. All participants confirmed
that they could see the checks clearly and got the
instruction to concentrate on the screen and focus on
the red fixation point in the middle of the checker-
board. During the session talking was not allowed.
Standard surface electrodes (cup gold electrodes,
GVB-geliMED KG, Bad Segeberg, Germany) were
attached to Oz (active electrode) and Fz (reference),
according to the 10/20 system (25). The ground elec-
trode was fixed on the right wrist with a ground strap.
Electrode impedances were kept below 5 k. A black-
and-white checkerboard reversal pattern presented on a
Viewsonic E70fsB Monitor (check size 510, reversal fre-
quency 3Hz, stimulated part of the visual field 14
degrees 10 degrees, Michelson’s contrast 90.5%,
mean luminance 52.5 cd/m2, vertical refresh rate:
60Hz) was used to evoke VEPs that were recorded
using an Oxford Instruments Medical EP system
(Software Version 11, Medelec Synergy, Old Woking,
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Surrey, UK). In total, 450 responses obtained by con-
tinuous stimulation were recorded between 0 and
300ms after stimulation, averaged in six consecutive
blocks of 75 responses and bandpass filtered from 1
to 100Hz. Traces were rejected automatically as arti-
facts if the signal amplitude exceeded 200 mV. The
number of rejected traces was below 10% for every
recording, therefore unlikely to affect the VEP habitu-
ation kinetics.
VEP data analysis
Individual N75 and P100 peaks of blocks 1 to 6 were
detected automatically and confirmed visually by the
investigator according to standard procedures (23).
N75 to P100 peak-to-peak amplitudes were calculated
and used as the measure of VEP amplitude in the present
study. Linear regression over blocks 1 to 6 VEP ampli-
tudes was used to determine the habituation slope. The
ratio between the VEP amplitudes of the sixth and the
first block in percentage (block ratio¼ [block 6 ampli-
tude/block 1 amplitude] * 100) was calculated and used
as a second measure of VEP habituation. Thus, larger
habituation is indicated by more negative habituation
slopes and smaller block ratios. Block 1 VEP amplitudes
were also analyzed to allow comparison with published
data on test-retest reliability of single-block VEP ampli-
tudes (26,27).
Statistics
Statistical analysis was performed using the Statistical
Package for Social Sciences (SPSS version 22, IBM
Corporation, Armonk, NY, USA). Values are pre-
sented as means and standard deviations (SD) unless
stated otherwise. Mean differences and correlations
were considered significant if the p value was p< 0.05.
The Kolmogorov-Smirnov-test was used to test for
normal distribution before the use of parametric tests.
Unpaired T-tests were used to test for group differences
in VEP block 1 amplitudes, habituation slopes and
block ratios. Test-retest reliability of block 1 ampli-
tudes, habituation slopes and block ratios was assessed
(1) at the group level by comparing test and retest
group mean values using paired T-tests and (2) at the
individual level by calculating ICCs, two-way mixed,
single measure, absolute agreement). Effect sizes were
quantified using Cohen’s d.
Results
Group differences
Characteristics of the study population are given in
Table 1. Age and sex were not significantly different
between migraine patients and controls (age: T(79)¼
0.95, p¼ 0.35, sex: 2(1)¼ 0.6, p¼ 0.43). VEP habitu-
ation profiles of migraine patients (n¼ 41) and controls
(n¼ 40) are shown in Figure 1. Mean values and results
of statistical tests are shown in Table 2. VEP block 1
amplitudes were not significantly different between
groups. However, VEP habituation was signifi-
cantly larger (i.e. more negative slopes and smaller
block ratios) in controls than in migraine patients,
with effect sizes (Cohen’s d) of 0.39 (slope) and 0.64
(block ratio).
Test-retest reliability over 15 minutes
Test-retest reliability of block 1 amplitudes, habituation
slopes and block ratios over 15 minutes was assessed in
15 migraine patients and 15 controls. Mean values
and results of statistical tests are given in Table 3,
and correlation plots are shown in Figure 2(a1)–(a3).
Table 1. Description of the cohort. SD is given in parentheses.
Group differences
Test-retest
Two to three weeks
Test-retest
15 minutes
Group Migraine Control Migraine Control Migraine Control
n 41 40 15 24 15 15
Age (years) 30 (10) 28 (8) 35 (12) 26 (7) 31 (12) 31 (8)
Gender (male:female) 3:38 5:35 1:14 2:22 2:13 2:13
Type (with aura:without aura) 3:38 – 0:15 – 3:12 –
Headache history (years) 13.6 (9.9) – 17.9 (13.5) – 16.7 (13.4) –
Headache days/month 4.4 (2.3) – 4.1 (2.3) – 3.9 (2.2) –
Headache intensity (1–10) 6.8 (1.5) – 7.1 (1.6) – 6.7 (1.9) –
MIDAS score 20.0 (19.5) – 21.5 (16.4) – 19.9 (16.1) –
MIDAS: Migraine Disability Assessment Scale.









































































Figure 1. Group differences in visual-evoked potential (VEP) habituation.
(a) VEP (N75–P100) amplitudes (mean SEM) over six blocks (75 stimuli each) are shown for healthy controls and migraine patients
(measured in the interictal period). Regression lines illustrate habituation slopes in interictal migraine patients vs. controls.
(b) VEP amplitude habituation slopes (mean SEM) of healthy controls and migraine patients in the interictal period are illustrated.
Habituation slopes were calculated from individual block amplitudes over block 1 to block 6 with least squares linear regression.
Habituation slopes were significantly more negative in controls than in interictal migraine patients.
(c) VEP amplitude block ratios are illustrated (mean SEM). Block ratios are block 6 VEP amplitudes expressed in percentage of block
1 VEP amplitudes. Block ratios were significantly higher in migraine patients measured in the interictal period than in controls.
Table 3. Reliability of VEP amplitudes and habituation after 15 minutes retesting in interictal migraine patients and in controls. SD is
given in parentheses. Block 1 amplitude indicates the first block peak to peak amplitude. Slope shows off the slope of the linear
regression over block 1 to block 6 amplitudes. Block ratio indicates block 6 amplitude in percentage of block 1 amplitude.
Test-retest 15 minutes
Migraine Control



































VEP: visual-evoked potential; ICC: intraclass correlation coefficient.
Table 2. Group comparison of visual-evoked potential (VEP) amplitudes and habituation. SD is given in parentheses. Block I amp-
litude indicates the first block peak to peak amplitude. Slope shows off the slope of the linear regression over block 1 to block 6






Block I amplitude (mV) 12.2 (3.8) 11.0 (4.4) T(79)¼1.3
p¼ 0.20
0.29
Slope (mV/block) 0.04 (0.46) 0.21 (0.40) T(79)¼2.6
p¼ 0.012
0.39




In controls, mean values at test and retest were similar
for all parameters (p> 0.1). Correlations between test
and retest values were high for block 1 amplitudes
(ICC¼ 0.75) but low for habituation slopes and block
ratios (ICC¼ 0.21 and 0.13, respectively). Similarly,
there were also no significant differences between
test and retest values for any of the tested parameters
in migraine patients (p> 0.1). Test-retest correlations
in migraine patients were high for block 1 amplitudes
(ICC¼ 0.74), but low for habituation slopes (ICC¼
0.30) and for block ratios (ICC¼0.06). Although
none of the differences reached statistical significance,
it must be noted that both in the migraine and control
groups, habituation slopes were less negative at the
15-minute retest, and block ratios were increased.
Effect sizes reached values between 0.18 and 0.59,
which is partially within the range of effect sizes
found for the difference between migraine patients
and controls (d¼ 0.39 and 0.64, see Table 2).
Test-retest reliability over two to three weeks
Test-retest reliability of block 1 amplitudes, habituation
slopes and block ratios over two to three weeks
was assessed in 15 migraine patients and 24 controls.
Mean values and results of statistical tests are given
in Table 4, and correlation plots are shown in




















































































































































Figure 2. Test-retest reliability of visual-evoked potential (VEP) measures.
(a1)–(a3) Test-retest reliability over 15 minutes (15 migraine patients, 15 controls). Correlations between VEP measures at test and
retest are illustrated. Linear regression lines are shown.
(b1)–(b3) Test-retest reliability over two to three weeks (15 migraine patients and 24 controls). Correlations between VEP measures
at test and retest are illustrated. Linear regression lines are shown.
VEP measures were as follows: Block 1 amplitudes are first-block VEP (N75–P100) amplitudes. Habituation slopes were calculated
from individual VEP block amplitudes over block 1 to block 6 with least squares linear regression. Block ratios were calculated as block
6 VEP amplitudes expressed in percentage of block 1 VEP amplitudes.
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and retest were similar for all parameters (p> 0.5).
Correlations between test and retest values were high
for block 1 amplitudes (ICC¼ 0.75) but low for habitu-
ation slopes and block ratios (ICC¼ 0.07 and 0.30,
respectively). For migraine patients, block 1 amplitudes
were significantly higher at retest and habituation
slopes and block ratios were significantly lower at
retest (all p< 0.05). Test-retest correlations were high
for block 1 amplitudes (ICC¼ 0.91), moderate for
habituation slopes (ICC¼ 0.59) and low for block
ratios (ICC¼ 0.34).
Habituation slopes between test and retest after 15
minutes and after two to three weeks were slightly differ-
ent. In controls, habituation slopes tended to be more
negative at the 15-minute test than at the retest
(slope(test)¼0.22 0.43; slope(retest)¼0.01 0.43)
(p¼ 0.16). Migraine patients showed no difference at the
retest after 15 minutes compared to the first experimental
session (slope(test)¼ 0.03 0.40; slope(retest)¼ 0.10
 0.37) (p¼ 0.54).
Habituation slopes for test and retest after two to
three weeks showed different results. Both groups
showed more habituation at the retest session, but this
was not significantly different for controls. In contrast,
migraine patients showed a significantly different habitu-
ation between test and retest (controls: slope(test)¼
0.19 0.33, slope(retest)¼0.26 0.50 (p¼ 0.56);
migraine patients: slope(test)¼ 0.08 0.34, slope(retest)¼
0.18 0.50 (p¼ 0.020)).
Discussion
Main results of the present study are: (1) deficient inter-
ictal VEP habituation was confirmed in episodic
migraine patients, (2) VEP habituation group mean
values showed significantly increased habituation in
the migraine group at the two- to three-week retest,
and (3) correlations between VEP habituation measures
at test and retest were disappointing, both for the 15
minutes and the two- to three-week interval.
To the best of our knowledge, test-retest reliability
of VEP habituation has not been assessed before. Test-
retest reliability of VEP P100 latencies has been
assessed before and yielded test-retest correlation coef-
ficients around 0.7 over an unspecified interval (28) and
of 0.59–0.93 over eight months (27). Test-retest reliabil-
ity of VEP N75–P100 amplitudes (a single block of 100
trials) has been shown to be good over eight months
(r¼ 0.72) (27). This is consistent with the results of the
present study, in which test-retest ICCs of block 1 VEP
amplitudes were above 0.74 for both test-retest inter-
vals and both groups. In contrast, test-retest correl-
ations of VEP habituation measures were mostly poor
(ICC 0.07 to 0.59 for two to three weeks) in the present
study, suggesting that VEP habituation may not be the
best way to monitor individual changes of cortical
excitability over time. Previous studies have shown
that cortical excitability and habituation are dependent
on the migraine cycle, with a maximum habituation
deficit immediately before the attack and normalization
of the habituation during the attack (4,29). These stu-
dies showed that every patient may be driven by his or
her own ‘‘migraine-rhythm.’’ Therefore, we hypothe-
sized that the poor test-retest correlations found over
the two- to three-week interval might be due to unpre-
dictable changes of cortical excitability during the indi-
vidually varying migraine cycle (although all
measurements were conducted in the interictal period
as documented by telephone interview two days after
the recordings). To exclude this possibility, we con-
ducted an additional set of experiments investigating
test-retest reliability over 15 minutes. However,
Table 4. Reliability of VEP amplitudes and habituation after two to three weeks retesting in interictal migraine patients and in
controls. SD is given in parentheses. Block 1 amplitude indicates the first block peak to peak amplitude. Slope shows off the slope of
the linear regression over block 1 to block 6 amplitudes. Block ratio indicates block 6 amplitude in percentage of block 1 amplitude.









































VEP: visual-evoked potential; ICC: intraclass correlation coefficient.
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correlations between VEP habituation at baseline and
15 minutes later were also poor (ICC 0.06 to 0.30),
suggesting a large inherent variability of VEP habitu-
ation as quantified by habituation slopes and block
ratios instead of physiological changes over time as
the cause of poor test-retest correlations.
Other measures of cortical excitability also differen-
tiate between migraine patients and controls and may
exhibit better test-retest reliability than VEP habitu-
ation. Contingent negative variation (CNV) amplitudes
are increased in migraine patients compared to controls
(4,30). Test-retest reliability of CNV over 10 days has
been examined by Kropp et al. (31) in 27 healthy vol-
unteers. Test-retest correlation coefficients were good,
especially for the early CNV component (iCNV,
Pearson’s r¼ 0.86). The authors concluded that the
standardized CNV recording procedure is reproducible
and stable in healthy individuals. Therefore, the
early CNV component may be more suitable to
follow individual changes over time than VEP habitu-
ation, but this has not been shown until now in
migraine patients.
In addition to mostly poor test-retest correlations of
VEP habituation, our results also indicate that group
mean values of VEP habituation measures may not
necessarily be stable over time. Importantly, there was
a significant increase in habituation in the migraine
group over the two- to three-week interval. For the
15-minute interval, a possible systematic shift toward
smaller habituation at retest compared to test was
observed both in the migraine and the control groups,
which has to be interpreted with much caution because
it did not reach significance. The reasons for these shifts
over time are not clear. It has been described that
habituation may increase after repeated stimulation
(32). This might in part explain the increase in habitu-
ation in the migraine group after two to three weeks,
but is at variance with the possible shift toward smaller
habituation over 15 minutes. However, in most experi-
mental settings, net results of habituation are caused by
the sum of concurrent habituation and sensitization
processes that occur with different kinetics and there-
fore may give different results depending on the tested
time frame (‘‘dual-process theory’’ (32)). In migraine, it
is strongly debated if the lack of net habituation seen,
e.g. in VEP recordings, is the result of increased cortical
excitability (leading to decreased habituation) or the
result of decreased cortical pre-activation levels
(leading to decreased VEP amplitudes at stimulation
onset, which implies that according to the ‘‘ceiling
model’’ of cortical excitation, the threshold for initi-
ation of habitation is reached later in migraine patients
than controls) (6,33). Therefore, habituation in
migraine might also involve a combination of both
mechanisms, possibly with different kinetics.
Several studies have monitored VEP amplitudes or
habituation in parallel with clinical outcome during
preventive migraine treatment (34–36). Diener et al.
(34) recorded a single block (64 trials) of VEPs before
and after four months of preventive treatment with beta
blockers in 41 migraine patients. Migraine patients had
significantly higher VEP amplitudes than healthy vol-
unteers at baseline. The use of beta blockers led to a
significant decrease in VEP amplitude in migraine
patients, but was not related to the clinical treatment
effect. After three months of washout, VEP amplitudes
partially returned to the initial values. VEP habituation
was not tested in this study. Ozkul and Bozlar (35)
monitored the effect of fluoxetine on interictal VEP
habituation (five blocks of 50 trials) in 79 migraine
patients. At baseline, VEP block ratios were signifi-
cantly higher in migraine patients compared to con-
trols. After four weeks of fluoxetine, VEP block ratios
were similar to the baseline values of the control group.
A correlation with the clinical effect was not reported.
One study also examined treatment effects over a
15-minute interval. Viganò et al. (36) recorded VEP
habituation slopes (over six blocks of 100 trials)
before and after 15 minutes of anodal transcranial
direct current stimulation (tDCS) over the visual
cortex, and again three hours later in 11 controls and
13 interictal migraine patients. VEP habituation slopes
were significantly more negative after tDCS both in
migraine patients and controls, and back to baseline
values after three hours. Our data suggest that there
may be a systematic shift in VEP habituation at the
retest interval of 15 minutes, which may compromise
the interpretation of treatment effects at this time
window. However, in the cited study (36) the treatment
effect was in the direction of increased habituation,
while the systematic shift detected in the present study
was in the direction of reduced habituation, suggesting
that the effect of tDCS on VEP habituation was real.
Nonetheless, our results, showing that VEP habituation
is not necessarily stable over time, underline that treat-
ment studies should always include a group with sham
treatment or without treatment to determine the nat-
ural course of VEP habituation over the investigated
time interval.
To the best of our knowledge, the present study is
the first to investigate test-retest reliability of VEP
habituation. An important limitation was the relatively
small number of participants in the test-retest part of
the study. However, the number was sufficient to show
a significant increase in VEP habituation in migraine
patients over the two- to three-week interval. Another
limitation is the fact that we pooled together migraine
patients with and without aura. However, there were
only three migraine patients with aura, suggesting that
their inclusion cannot affect fundamentally the results.
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A strength of the study is that participants of both
groups were recruited from the general population.
Including patients from a tertiary care facility might
significantly bias the results because these patients are
usually severely affected. A further strength of the study
is the care that was taken to include individuals only
during the interictal period (48 hours before and after
the measurement). A further limitation is the relatively
low mean age in the present study, limiting the gener-
alizability of the results to older individuals. However,
migraine is a disorder that is most prevalent in younger
adults (37).
Conclusion
VEP habituation is not generally suitable to assess
longitudinal changes of cortical excitability at an
individual level. It may be acceptable for monitoring
treatment effects at the group level, provided the
group size is large enough, and a control group without
treatment or with sham treatment is included since
the VEP habituation may also change in these patients
over time.
Article highlights
. A significantly larger visual-evoked potential (VEP) habituation was found in controls compared to inter-
ictal migraine patients.
. VEP habituation in migraine patients showed a significant shift toward larger habituation at the two- to
three-week retest interval, indicating that a sham treatment group should be included in studies using VEP
habitation as a measure of treatment outcome.
. Test-retest reliability of VEP habituation was insufficient to follow individual changes of cortical excitability
over time.
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